Skip to main content
SpringerLink
Log in

Sucroferric oxyhydroxide cost effective in Scotland

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2012 British pounds

Reference

  • Gutzwiller FS, et al. Cost Effectiveness of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in the Treatment of Hyperphosphataemia in Patients Receiving Dialysis, from the Perspective of the National Health Service in Scotland. PharmacoEconomics : 3 Sep 2015. Available from: URL: http://doi.org/10.1007/s40273-015-0320-9

    PubMed Central  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sucroferric oxyhydroxide cost effective in Scotland. PharmacoEcon Outcomes News 736, 21 (2015). https://doi.org/10.1007/s40274-015-2431-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2431-0

Search

Navigation